PORTLAND, Ore.--(BUSINESS WIRE)--Calypte Biomedical Corporation (OTCBB: CBMC), a developer, manufacturer and marketer of HIV diagnostic tests, announced today that, in honor of World AIDS Day, it has donated 4,000 Aware™ HIV-1/2 OMT (oral fluid) tests to the National AIDS Control Council (NACC) of the Republic of Kenya, in conjunction with its distributor in Kenya, Ultralab & Allied Services Ltd. The tests being donated to NACC will be used in a pilot program utilizing oral fluid and rapid HIV testing with the objective of expanding Kenya’s current blood-only testing protocol to include an oral fluid testing alternative. The current donation is in addition to the 10,000 Aware™ HIV-1/2 OMT tests that Calypte donated previously to the Ministry of Health and the National HIV/AIDS and STD Control Program (NASCOP). Some of the tests donated previously were used by NASCOP in a comparative study demonstrating that the performance of an oral fluid HIV testing algorithm is comparable to or better than Kenya’s current blood-based algorithm.
